Search Results

There are 156598 results for: content related to: Management of cancer patients receiving interferon alfa-2a

  1. Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects

    Clinical Pharmacology & Therapeutics

    Volume 59, Issue 6, June 1996, Pages: 636–646, Keith A. Nieforth, Rosemary Nadeau, Indravadan H. Patel and Diane Mould

    Article first published online : 13 JUN 1996, DOI: 10.1016/S0009-9236(96)90003-X

  2. Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: A progress report

    International Journal of Cancer

    Volume 39, Issue S1, 1987, Pages: 36–40, S. D. Fosså and S. T. De Garis

    Article first published online : 17 JUL 2006, DOI: 10.1002/ijc.2910390708

  3. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22017

  4. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Article first published online : 5 OCT 2005, DOI: 10.1002/hep.20927

  5. You have free access to this content
    Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1719–1726, Vinod K. Rustgi, William M. Lee, Eric Lawitz, Stuart C. Gordon, Nezam Afdhal, Fred Poordad, Herbert L. Bonkovsky, Leif Bengtsson, Gurudatt Chandorkar, Matthew Harding, Lindsay McNair, Molly Aalyson, John Alam, Robert Kauffman, Shahin Gharakhanian, John G. McHutchison and MErimepodib TRiple cOmbination (METRO) study group

    Article first published online : 5 AUG 2009, DOI: 10.1002/hep.23204

  6. Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

    Liver International

    Balazs Fülöp, Michael Biermer, Markus Cornberg, Heiner Wedemeyer, Kerstin Port, Renate Heyne, Stefan Zeuzem, Kai-Henrik Peiffer, Tania Welzel, Adam Herber, Peter Buggisch, Christoph Moser, Sabine Stoll, Ulrich Alshuth and Thomas Berg

    Article first published online : 20 APR 2015, DOI: 10.1111/liv.12832

  7. You have free access to this content
    Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin

    Hepatology

    Volume 48, Issue 4, October 2008, Pages: 1033–1043, Michael W. Fried, Donald M. Jensen, Maribel Rodriguez-Torres, Lisa M. Nyberg, Adrian M. Di Bisceglie, Timothy R. Morgan, Paul J. Pockros, Amy Lin, Lisa Cupelli, Frank Duff, Ka Wang and David R. Nelson

    Article first published online : 9 JUN 2008, DOI: 10.1002/hep.22448

  8. Recombinant interferon alfa-2a in advanced malignant melanoma. a phase i-ii study in combination with dtic

    International Journal of Cancer

    Volume 39, Issue S1, 1987, Pages: 31–35, G. R. C. McLeod, D. B. Thomson and P. Hersey

    Article first published online : 18 JUL 2006, DOI: 10.1002/ijc.2910390707

  9. You have free access to this content
    Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1251–1267, F. F. POORDAD

    Article first published online : 17 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04300.x

  10. Comparison of the Effects of Intralesional Interferon Alfa-2a, 2b and the Combination of 2a and 2b in the Treatment of Basal Cell Carcinoma

    The Journal of Dermatology

    Volume 23, Issue 6, June 1996, Pages: 394–396, Erkan Alpsoy, Ertan Yilmaz, Erdal Başaran and Şahin Yazar

    Article first published online : 9 APR 2015, DOI: 10.1111/j.1346-8138.1996.tb04040.x

  11. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  12. In vivo interferon system assessed by 2′-5′ oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin

    Hepatology Research

    Volume 38, Issue 12, December 2008, Pages: 1213–1220, Michiko Shindo, Kazushige Hamada, Teruhisa Morikawa, Yuichi Harano, Tomoaki Nakajima and Tadao Okuno

    Article first published online : 18 AUG 2008, DOI: 10.1111/j.1872-034X.2008.00397.x

  13. Pegylated interferons for chronic hepatitis C virus infection: an indirect analysis of randomized trials

    Journal of Viral Hepatitis

    Volume 15, Issue 8, August 2008, Pages: 551–570, R. Chou, S. Carson and B. K. S. Chan

    Article first published online : 14 MAY 2008, DOI: 10.1111/j.1365-2893.2008.00984.x

  14. You have free access to this content
    The preclinical development of roferon®-A

    Cancer

    Volume 57, Issue S8, 15 April 1986, Pages: 1648–1656, Patrick W. Trown, Robert J. Wills and Jerome J. Kamm

    Article first published online : 28 JUN 2006, DOI: 10.1002/1097-0142(19860415)57:8+<1648::AID-CNCR2820571303>3.0.CO;2-O

  15. You have free access to this content
    Results of the IDEAL trial: “Mirror, mirror on the wall … Which's the fairest peg-interferon of them all?”

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 2034–2037, Julian Schulze zur Wiesch and Ansgar W. Lohse

    Article first published online : 20 NOV 2009, DOI: 10.1002/hep.23376

  16. Current Therapies for Chronic Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 92–111, McKenzie C. Ferguson

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.1.92

  17. You have free access to this content
    Treatment of chronic hepatitis C in hemodialysis patients

    Hepatology

    Volume 48, Issue 5, November 2008, Pages: 1690–1699, Marina Berenguer

    Article first published online : 28 JUL 2008, DOI: 10.1002/hep.22545

  18. You have free access to this content
    Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: A meta-analysis of individual patient data

    Hepatology

    Volume 39, Issue 2, February 2004, Pages: 333–342, Calogero Cammà, Danilo Di Bona, Filippo Schepis, E. Jenny Heathcote, Stefan Zeuzem, Paul J. Pockros, Patrick Marcellin, Luis Balart, Alfredo Alberti and Antonio Craxì

    Article first published online : 30 JAN 2004, DOI: 10.1002/hep.20073

  19. You have free access to this content
    Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1141–1150, Maurizia Rossana Brunetto, Francesco Moriconi, Ferruccio Bonino, George K. K. Lau, Patrizia Farci, Cihan Yurdaydin, Teerha Piratvisuth, Kangxian Luo, Yuming Wang, Stephanos Hadziyannis, Eva Wolf, Philip McCloud, Richard Batrla and Patrick Marcellin

    Article first published online : 2 DEC 2008, DOI: 10.1002/hep.22760

  20. You have free access to this content
    Therapy of hepatitis C: Interferon alfa-2a trials

    Hepatology

    Volume 26, Issue S3, December 1997, Pages: 89S–95S, W M Lee

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510260716